XML 43 R31.htm IDEA: XBRL DOCUMENT v3.25.0.1
STOCK-BASED COMPENSATION (Tables)
9 Months Ended
Dec. 31, 2024
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions [Table Text Block]

The stock options are valued using a Black-Scholes Pricing Model, and Market-based RSUs are valued based on a lattice model, with the following assumptions:

 

    Granted in Fiscal 2025     Granted in Fiscal 2024  
Expected life of options   5 years     5 years  
Vested options     100 %     100 %
Risk-free interest rate     4.49 %     5.24 %
Expected volatility     174 %     175 %
Expected dividend yield   Nil     Nil  
Nonvested Restricted Stock Shares Activity [Table Text Block]

The expense associated with share-based payments to employees, directors, advisors, and contractors is allocated over the vesting or service period and recognized in the Selling, general, and administrative expenses (including research and development). For the nine months ended December 31, 2024, the Company’s share-based expense and option-based expense shown in Selling, general, and administrative expenses (including research and development) were $815 thousand and $435 thousand, respectively, and for the nine months ended December 31, 2023, the Company’s share-based expense and option-based expense was $1.4 million and $9 thousand, respectively.

 

Non-vested shares 

Shares

(in thousands)

(#)

  

Weighted
average

grant date fair
value

($)

 
Non-vested shares as of March 31, 2024   7,452    0.61 
Granted   -    - 
Vested   (150)   0.43 
Cancelled/forfeited   (30)   0.30 
Non-vested shares as of December 31, 2024   7,272    0.61 
Share-Based Payment Arrangement, Option, Activity [Table Text Block]
Options 

Shares

(in thousands)

(#)

  

Weighted
average

grant date fair
value

($)

  

Weighted
average

exercise price

($)

 
Options outstanding as of March 31, 2024   3,710    0.25    0.29 
Granted   -    -    - 
Exercised   -    -    - 
Cancelled/forfeited   -    -    - 
Options outstanding as of December 31, 2024   3,710    0.25    0.29